West Pharmaceutical Services, Inc. (WST)

In October 2025, WST shares jumped after strong third-quarter results and raised financial forecast. In September 2025, the stock gained following a research note indicating positive momentum in the bioprocessing sector. In February 2025, West Pharmaceutical Services' stock prices plummeted after releasing its FY 2023 results and issuing a disappointing full-year topline and earnings guidance for 2024, but rebounded significantly later.

The provided search results do not contain explicit information about the demand seasonality for West Pharmaceutical Services, Inc.'s products and services. However, the company's business is deeply integrated into the pharmaceutical and biotechnology industries, which generally experience consistent demand due to ongoing healthcare needs and drug development, suggesting a relatively stable demand rather than significant seasonality.

West Pharmaceutical Services, Inc. (WST) is a U.S.-based pharmaceutical company specializing in injectable pharmaceutical packaging and delivery systems, operating within the Health Technology and Healthcare sector. The company's products and services include vial containment solutions, pre-fillable systems, self-injection systems like the SmartDose electronic wearable injector, cartridge systems and components, intradermal delivery products, proprietary products, contract-manufactured products, and analytical services.

West Pharmaceutical Services, Inc. has a diversified global footprint, with approximately 55% of its revenue generated from international markets and 45% from the United States. The company serves customers in numerous countries across North and South America, Europe, Asia, and Australia.

West Pharmaceutical Services Inc. has a strong brand reputation as a premier supplier in the pharmaceutical and biotech industries, known for high-quality elastomer-based packaging components and innovative drug delivery systems. The company's brand is synonymous with reliability and excellence, enabling WST to secure long-term contracts with leading pharmaceutical companies.

West Pharmaceutical Services, Inc. (WST) is primarily owned by institutional shareholders, with approximately 97.16% of the company's stock held by them. Donald E. Morel Jr. is the largest individual shareholder, owning 1.11% of the company. Insiders hold 3.76% of the company's stock.